Cargando…
Prospective Pilot Study of a Single Daily Dosage of Trientine for the Treatment of Wilson Disease
BACKGROUND: Wilson disease requires lifelong therapy, currently given daily in multiple divided dosages. AIM: To prospectively evaluate once-daily trientine as therapy for Wilson disease. METHODS: Study group: eight patients (seven males) aged 22–71 years with stable Wilson disease treated from 4 to...
Autores principales: | Ala, Aftab, Aliu, Ermal, Schilsky, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427615/ https://www.ncbi.nlm.nih.gov/pubmed/25605552 http://dx.doi.org/10.1007/s10620-014-3495-6 |
Ejemplares similares
-
Trientine dihydrochloride for Wilson’s disease
Publicado: (2021) -
Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature
por: Boga, Salih, et al.
Publicado: (2015) -
Trientine-induced Rhabdomyolysis in an Adolescent with Wilson's Disease
por: Aslan, Nagehan, et al.
Publicado: (2019) -
Efficacy and Safety of Two Salts of Trientine in the Treatment of Wilson’s Disease
por: Woimant, France, et al.
Publicado: (2022) -
Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations
por: Camarata, Michelle A., et al.
Publicado: (2019)